New update on dry Macular Degeneration treatment: SYFOVRE® (pegcetacoplan injection) from Apellis Pharmaceuticals
On August 22, 2023, Apellis Pharmaceuticals provided an update on their SYFOVRE® (pegcetacoplan injection) treatment for Dry Macular Degeneration.
Check out thier press release for more information here.